Top Biotechnology Companies in Indonesia

The biotechnology industry in Indonesia is a rapidly growing sector that has become increasingly important to the country's economy. In this article, we will explore the key statistics from 2022, factors contributing to its growth and success, industry growth and comparison to previous years, key trends including technological disruptions, challenges, and future outlook.

read full article below
Filter bySearch by company name, registration number or domain name
CompanyHeadcountContactDescriptionDecision Maker
PUF SAINS LAB, PT.7 +62 816-1839-988
info@psl.id

PSL Puf Sains Lab is an inovation and also a manufacturing company offering high quality natural and high purity chemicals for various industries along with laboratory services, regulatory compliance services, and private label manufacturing services, mainly for e-liquid. In 2019 PT Puf Sains Lab received several awards, some of which were from LEPRID (World Indonesian Record Achievement Institute) for the inovation in the field of nicotine inventions and innovations, NICSAL 99+ and FB 99+. PT Puf Sains Lab together with succeeded in their first discovery, a new type of nicotine salt called Nicsal99+, then followed by a new type of nicotine freebase, call FB 99+. Next discovery is to formulate herbal (non-nicotine) e-liquids for health that can be consumed through a vaporizer system. All these innovations have been granted and protected by patents. PT Puf Sains Lab continue to conduct various researches to further innovations in the field of biotechnology.

OCEANOGEN3 +62 251 8368914
contact@oceanogen.com

We provide several services for laboratory testing, research and development services in natural sciences, research and development services in biotechnology and engineering, research and development services in fisheries and marine science, including comprehensive genetic testing for environmental biotechnology, exploration of marine biodiversity; to private and national biodiversity consultants. The main focus of our services is molecular biology and marine biodiversity.

PT LABQUIP INDOPRIMA16 +65 6778 3255
mahendran@labquipasia.com

PT Labquip Indoprima is a subsidiary of Labquip Group, a leading distributor for laboratory and medical equipment. We have been in the service of research institutes, hospitals, schools, government agencies, industrial sectors, private testing labs, and many more, for over 30 years in Singapore. We have offices in 8 countries, Singapore, Malaysia, Indonesia, India, Thailand, Taiwan, Vietnam and Philippines. We are not only a business but a growing family. The Labquip Family is present in all Southeast Asian countries and together, we have an integrated sales / marketing / support force in the whole region. Labquip has a proven track record of partnerships with our suppliers and clients in every country in Asia. For more information, please visit www.labquipasia.com and www.labivf.com or email to clarissa@labquipasia.com / mahendran@labquipasia.com

PT. BIOGEN SCIENTIFIC65 +62 274 2872895
(blank)

We are the distritributors of medical device and laboratory equipment product. Our principal parterns are Leica Biosystems, Leica Microsystems, Elitech Biomedical System, Novacyt, Peqlab, Citotest, Thermo Scientific, VWR, Agdia, Neogen, Tarson, Becton Dickinson (BD).

ENVIRO MEDITECH PRATAMA16 +62 21 3503011
info@enviromeditech.com

We have learned over more than 3 decades in various fields of health, environment, and technology, giving us the intuition to commit to, accommodate and be part of a better transformation for health services and the environment on Mother Earth. This is a form of gratitude and a form of our nationalism in the life of the nation as well as a concern for fellow living beings and nature.

ROTE KARAGINAN NUSANTARA10 +62 811-3609-888
info@rotecarrageenan.com

PT.Rote Karaginan Nusantara (RKN) is a subsidiary of Portvest Group,a family owned enterprise established in 2016 in Kupang, Indonesia. Our processing plant, is the most advanced and largest Carrageenan processing plant in Southeast Indonesia is located 25km south of Kupang, the capital of Nusa Tenggara Timur (NTT), a province deep in the southeast of Indonesia. NTT is the biggest and best raw seaweed producer in Indonesia and establishing our plant here enables us to secure raw quality seaweed supply for processing, some of which comes from our sister company Pesona Lautan Nusantara (PLN) that specializes in seaweed plantation aquaculture and Bioculture.

INSTITUT TEKNOLOGI DEL228 +62 632 331116
info@del.ac.id

DEL dimaknai sebagai Pemimpin yang Selangkah Lebih Maju. Yayasan Del mulai aktif di kegiatan sosial kemasyarakatan jauh sebelum didirikannya PT Toba Sejahtera, perusahaan yang kemudian menjadi Yayasan Del sebagai tonggak tanggung jawab sosial perusahaan. Tujuan awal Yayasan Del didirikan adalah untuk memberikan akses pendidikan berkualitas di daerah terpencil bagi siswa/i berprestasi dengan latar belakang ekonomi yang kurang menguntungkan, yaitu dengan mendirikan Politeknik Informatika Del dan SMA Unggul Del di Laguboti, Sumatera Utara serta Sekolah NOAH di Kalisari, Jakarta Timur. Tidak hanya berkiprah di bidang pendidikan, Yayasan Del juga aktif bekerjasama dengan pemerintah daerah dan lembaga sosial yang ada di Indonesia untuk meningkatkan pelayanan serta memperluas cakrawala bidang pelayanan strategis lainnya. Politeknik Informatika Del didirikan pada tahun 2001 dan bertujuan untuk menyediakan pendidikan tinggi berkualitas internasional, bagi siswa/i berpotensi, terutama dengan…

PT RISET PERKEBUNAN NUSANTARA54 +62 251 8328516
rpn@rpn.co.id

RPN is an Indonesian research-based company, a subsidiary of Holding Perkebunan Nusantara, in plantation crops generating innovation and increasing expertise capacity on all aspects of plantation agribusiness by providing integrated services (one stop serving) for the needs of seeds, production facilities, technology, services, economic analysis and policies for the triumph of the national plantation industry.

ESCO UTAMA25 (blank)
mail@escolifesciences.com

Bagian dari Esco Lifesciences Group, perusahaan global Singapura dengan pabrik dan kantor cabang di 43 lokasi di seluruh dunia. Esco membangun ekosistem sinergi di bidang alat, diagnostik, dan teknologi life sciences untuk meningkatkan kehidupan manusia.

PT MANDIRI PALMERA AGRINDO23 +62 21 5264983
humas@mpa.co.id

PT Mandiri Palmera Agrindo is private held company which runs trading, industrial, plantation & logistics services company, currently has its own manufacturer for CPO (Crude Palm Oil) also Palm Plantation as well located in South Sulawesi and head office in Jakarta - Indonesia.

PT. LUHUR WIRATAMA3 +62 21 82740695
support@ptluhurwiratama.com

PT Luhur Wiratama established in 2010 with a limited company establishment deed. And being part of the digitalization development of IT Software and Medical Instruments. Luhur Wiratama provides innovative products and services that are convenient for both physicians and patients, based on competencies in bioinformatics and expertise in the field of molecular diagnostics (MDx).

BASE, INDONESIA63 +62 818-0811-0888
hello@base.co.id

Base believes every individual is unique, just like their skin. We enable everyone to get the best beauty experience and be more comfortable with their own skin, by creating vegan and organic skincare through a direct-to-consumer platform. Each of Base skincare products is powered by biotechnology-processed ingredients, and our consumers can find a targeted recommendation of Bases products through Smart Skin Test. Heavily driven by data and fully digitalized, Base is bringing the beauty experience to the next level in Indonesia.

NEURABOT LAB9 +62 895-1569-1077
lab@neurabot.ai

Neurabot is a Digital Laboratory Platform & medical AI data labelling software company devoted to developing AI solutions for conquering cancer, treatment support & precision diagnostics 🔬 + 🧞♂️ Founded in 2019, development state-of-the-art technology and its application in digital pathology & medical images for cancer analysis. Neurabot is based in Yogyakarta, Indonesia. Our Mission “Decentralize Cancer Diagnostics”, and will never rest until we discover the invisible and unknown territories of medicine by navigating the ambiguity with the help of Artificial Intelligence & Digital Laboratory 4.0 Platform Collaboration : lab@neurabot.ai

INDONESIAN RESEARCH INSTITUTE FOR BIOTECHNOLOGY AND BIOINDUSTRY (IRIBB)30 +62 251 8324048
admin@iribb.org

The Indonesian Research Institute for Biotechnology and Bioindustry (IRIBB) or known as Pusat Penelitian Bioteknologi dan Bioindustri in Bahasa Indonesia was founded in January 2015. The institute was the transformation from The Indonesian Biotechnology Research Institute for Estate Crops (IBRIEC), founded in February 1993 which was previously known as Bogor Research Institute for Estate Crops (Pusat Penelitian Perkebunan Bogor) established in 1989. This national research center was originally developed from a regional research center, namely Bogor Research Institute for Estate Crops (Bogor-RIEC/Balai Penelitian Perkebunan Bogor). The regional research center was established in 1968 by merging two research stations, namely the Balai Penelitian Perkebunan Besar (ex Centrale Proefstation Vereneging-CPV) and Balai Penelitian dan Pemakaian Karet (ex Indonesisch Instituut voor Rubber Onderzoek-INIRO). These two research stations had their own unique histories dated back to 1901, during the…

PT SCIENCEWERKE47 +65 6777 1045
enquiry@sciencewerke.com

Sciencewerke is a sales, marketing and distribution company focused on cutting-edge and emerging technologies in biomedical and life sciences. We provide instruments, reagents, consumables and services for the scientific, clinical, biotech and pharma communities.

PT BIOMEDIKAL SCIENTIFIC INDONESIA6 +62 21 27873307
info@bimasindo.com

Biomedikal Scientific Indonesia di dirikan di Jakarta berdasarkan Akta Notaris Rini Lestari, SH No.6 Tanggal 10 Januari 2020 sesuai Pasal 3 bahwa kegiatan usaha Perusahaan adalah perdagangan alat-alat kesehatan khusus nya alat-alat laboratorium.

MOOSA7 +62 821-7110-077
admin@moosagenetics.com

Moosa Genetic is a biotechnology firm specializing in genetically improving of local cattle and dairy herds using modern animal reproductive and molecular technologies. Since its inception in 2016, the company has quickly established itself as an industry leader, offering new solutions to help farmers and breeders improve the genetic quality of their herds.

ATMA JAYA CATHOLIC UNIVERSITY OF INDONESIA1,396 +62 877-7539-8770
fp@atmajaya.ac.id

Unika Atma Jaya is an award winning private university based in Jakarta. It ranked first as best private university in the Jakarta, Bogor, Depok, Bekasi, Tangerang area and second best private university in Indonesia in 2018. It is among the 17 Indonesian universities in the top best 400 universities in Asia according to QS ranking. It is awarded Indonesian National Standard (SN)) in gold category for four consecutive year (2015-2018). It is a recipient of numerous grants from the Ministry of Research, Technology and Higher Education. Its received an A accreditation in 2016 and is one of the 50 best promising universities in Indonesia. Founded on 1 June 1960, Unika Atma Jaya has 20 undergraduate study programs and 11 postgraduate study programs, and four professional program studies. It has 8 Faculties which are Faculty of Economics and Business, Faculty of Education and Language, Faculty of Law, Faculty of Psychology, Faculty of Business Administration and Communication Studies, Fac…

PT BIOTEK FARMASI INDONESIA31 +62 21 21241300
info@biotekfarmasiindonesia.com

Biotek Farmasi Indonesia is a company engaged in the health industry based Indonesia. The company is supported by manufacturing, research, development , and marketing activities. Over the past few years, the company has carried out a product research and development center in California, United States. In line with the provisions for producing high-quality and safe products for consumption, Biotek Farmasi Indonesia has obtained GMP (Good Manufacturing Practices) certification for its factory issued by the National Agency of Drug and Food Control Indonesia (NADFC Indonesia). Every product launched is Beyond Ordinary and has obtained Distribution Approval by NADFC Indonesia. Our company tagline “Beyond Ordinary”. Combined composition of materials from Biotek Farmasi Indonesia has not been found in the pharmaceutical industry market, because it has been specifically researched and developed by Biotek Farmasi Indonesia Scientifically. We developed our own raw material through biotechno…

PT. UBC MEDICAL INDONESIA45 +62 21 4608808
info@ubcindonesia.com

Kami akan mengubah kebutuhan Anda menjadi produk yang sukses berdasarkan komitmen kami terhadap tingkat kualitas, keunggulan operasional dan kepuasan pelanggan tertinggi. Ilmuwan dan insinyur kami adalah pemimpin di bidangnya, dan menawarkan kombinasi pengetahuan dan pengalaman yang berorientasi pada proyek dan sesuai dengan persyaratan peraturan.

Top Biotechnology Companies in Indonesia

Key Statistics from 2022

The biotechnology industry in Indonesia is projected to grow at an annual rate of 7% in 2022, contributing around 0.5% to the country's GDP. The industry is also a significant contributor to employment, providing jobs for over 300,000 people in 2022. Additionally, the industry is highly concentrated, with a few large companies accounting for the majority of the market share.

Factors Contributing to Growth and Success

Several factors have contributed to the growth and success of the biotechnology industry in Indonesia. One of the key contributors is the government's initiatives to promote the development of the industry, including the establishment of a biotechnology research and development center and the provision of tax incentives for biotechnology companies.

Additionally, the industry's growth is being driven by the increasing demand for biotechnology products and services in Indonesia and the region. The country's growing middle class is increasingly willing to spend on healthcare and related services, creating new opportunities for biotechnology companies.

Industry Growth and Comparison to Previous Years

The biotechnology industry in Indonesia has experienced significant growth in recent years, with the industry's growth rate expected to be 7% in 2022. This is an improvement from the previous year's growth rate of 6%. The industry's growth has been driven by the increasing demand for biotechnology products and services, as well as the government's initiatives to promote the development of the industry.

Key Trends Including Technological Disruptions

The biotechnology industry in Indonesia is experiencing significant technological disruptions, with the increasing use of advanced technologies such as genetic engineering, bioprocessing, and bioinformatics. This has enabled biotechnology companies to develop new products and services that are more efficient and effective, such as personalized medicine and gene therapies.

Another key trend in the industry is the increasing use of artificial intelligence and machine learning in biotechnology research and development. These technologies are enabling companies to identify and analyze large volumes of data more efficiently, facilitating the development of new drugs and therapies.

Challenges

As the biotechnology industry in Indonesia continues to grow, it also faces several challenges that must be addressed to ensure its long-term success. One of the key challenges is the need to develop a robust regulatory framework that can support the safe and effective development and commercialization of biotechnology products and services.

Other challenges include the need to address issues related to intellectual property protection and licensing, as well as the need to build strong partnerships with other stakeholders in the healthcare ecosystem, such as healthcare providers, insurers, and patient groups.

Future Outlook

As the biotechnology industry in Indonesia continues to grow and evolve, there are several key areas that are likely to shape its future outlook. One of the most significant areas of development is the increasing focus on precision medicine, which involves tailoring medical treatments to an individual's unique genetic makeup.

This approach has the potential to revolutionize healthcare in Indonesia, enabling more personalized and effective treatments for a range of diseases and conditions. It also presents significant opportunities for biotechnology companies to develop new products and services that can support the growing demand for precision medicine.

Another key area of development is the increasing use of digital technology in the biotechnology industry. This includes the use of artificial intelligence and machine learning to analyze large volumes of data and develop new insights and discoveries. It also includes the use of digital platforms to improve patient care and engagement, such as telemedicine and remote monitoring.

Conclusion

The biotechnology industry in Indonesia is a rapidly growing sector that is poised to continue its growth trajectory in the coming years. The industry's success is being driven by a range of factors, including the government's initiatives to promote the development of the industry, the increasing demand for biotechnology products and services, and the adoption of advanced technologies.

However, the industry must also address several challenges, such as the need to improve the quality and safety of biotechnology products and services and the need to comply with regulatory requirements. Overall, the future outlook for the biotechnology industry in Indonesia is positive, with new opportunities emerging as the country continues to develop and modernize.

To capitalize on these opportunities and overcome the challenges, the biotechnology industry in Indonesia must continue to invest in research and development, as well as develop strong partnerships with other stakeholders in the healthcare ecosystem.

In addition, the industry must also focus on developing a strong talent pool to support its growth. This includes investing in education and training programs that can help develop the next generation of biotechnology professionals in Indonesia.

Overall, the biotechnology industry in Indonesia is a growing sector with significant potential for future growth and success. By continuing to invest in research and development, leveraging advanced technologies, and developing strong partnerships with other stakeholders, the industry can continue to drive innovation and make a positive impact on the country's economy and society.

undefined's picture
By Melissa Goh
Published on 12 May 2023